(Reuters) -Novo Nordisk has cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, Bloomberg News reported on Friday, citing a statement.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber)
Brought to you by www.srnnews.com
